Report Detail
Global Peptide Receptor Radionuclide Therapy (PRRT) Market 2019 by Company, Regions, Type and Application, Forecast to 2024
- RnM3860239 |
- 26 December, 2019 |
- Global |
- 102 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Description
Scope of the Report:
The global Peptide Receptor Radionuclide Therapy (PRRT) market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Peptide Receptor Radionuclide Therapy (PRRT).
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Peptide Receptor Radionuclide Therapy (PRRT) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Peptide Receptor Radionuclide Therapy (PRRT) market by product type and applications/end industries.
Market Segment by Companies, this report covers
Novartis
Australasian Gastro-Intestinal Trials Group
ITM Solucin
National Institutes of Health
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Gastroenteropancreatic Neuroendocrine Tumor
Foregut Neuroendocrine Tumor
Midgut Neuroendocrine Tumor
Hindgut Neuroendocrine Tumor
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Table of Contents
1 Peptide Receptor Radionuclide Therapy (PRRT) Market Overview
- 1.1 Product Overview and Scope of Peptide Receptor Radionuclide Therapy (PRRT)
- 1.2 Classification of Peptide Receptor Radionuclide Therapy (PRRT) by Types
- 1.2.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Comparison by Types (2019-2024)
- 1.2.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Types in 2018
- 1.2.3 Gastroenteropancreatic Neuroendocrine Tumor
- 1.2.4 Foregut Neuroendocrine Tumor
- 1.2.5 Midgut Neuroendocrine Tumor
- 1.2.6 Hindgut Neuroendocrine Tumor
- 1.3 Global Peptide Receptor Radionuclide Therapy (PRRT) Market by Application
- 1.3.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Market Share Comparison by Applications (2014-2024)
- 1.3.2 Hospital Pharmacies
- 1.3.3 Retail Pharmacies
- 1.3.4 Online Pharmacies
- 1.4 Global Peptide Receptor Radionuclide Therapy (PRRT) Market by Regions
- 1.4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size (Million USD) Comparison by Regions (2014-2024)
- 1.4.1 North America (USA, Canada and Mexico) Peptide Receptor Radionuclide Therapy (PRRT) Status and Prospect (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy) Peptide Receptor Radionuclide Therapy (PRRT) Status and Prospect (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Peptide Receptor Radionuclide Therapy (PRRT) Status and Prospect (2014-2024)
- 1.4.4 South America (Brazil, Argentina, Colombia) Peptide Receptor Radionuclide Therapy (PRRT) Status and Prospect (2014-2024)
- 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Peptide Receptor Radionuclide Therapy (PRRT) Status and Prospect (2014-2024)
- 1.5 Global Market Size of Peptide Receptor Radionuclide Therapy (PRRT) (2014-2024)
2 Company Profiles
- 2.1 Novartis
- 2.1.1 Business Overview
- 2.1.2 Peptide Receptor Radionuclide Therapy (PRRT) Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 Australasian Gastro-Intestinal Trials Group
- 2.2.1 Business Overview
- 2.2.2 Peptide Receptor Radionuclide Therapy (PRRT) Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2017-2018)
- 2.3 ITM Solucin
- 2.3.1 Business Overview
- 2.3.2 Peptide Receptor Radionuclide Therapy (PRRT) Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2017-2018)
- 2.4 National Institutes of Health
- 2.4.1 Business Overview
- 2.4.2 Peptide Receptor Radionuclide Therapy (PRRT) Type and Applications
- 2.4.2.1 Product A
- 2.4.2.2 Product B
- 2.4.3 National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2017-2018)
3 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Competition, by Players
- 3.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Share by Players (2014-2019)
- 3.2 Market Concentration Rate
- 3.2.1 Top 5 Peptide Receptor Radionuclide Therapy (PRRT) Players Market Share
- 3.2.2 Top 10 Peptide Receptor Radionuclide Therapy (PRRT) Players Market Share
- 3.3 Market Competition Trend
4 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Regions
- 4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Market Share by Regions
- 4.2 North America Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
- 4.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
- 4.5 South America Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
5 North America Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Countries
- 5.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Countries (2014-2019)
- 5.2 USA Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
- 5.3 Canada Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
- 5.4 Mexico Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
6 Europe Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Countries
- 6.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Countries (2014-2019)
- 6.2 Germany Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
- 6.3 UK Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
- 6.4 France Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
- 6.5 Russia Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
- 6.6 Italy Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Countries
- 7.1 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Countries (2014-2019)
- 7.2 China Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
- 7.3 Japan Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
- 7.4 Korea Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
- 7.5 India Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
- 7.6 Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
8 South America Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Countries
- 8.1 South America Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Countries (2014-2019)
- 8.2 Brazil Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
- 8.3 Argentina Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
- 8.4 Colombia Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Peptide Receptor Radionuclide Therapy (PRRT) by Countries
- 9.1 Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Countries (2014-2019)
- 9.2 Saudi Arabia Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
- 9.3 UAE Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
- 9.4 Egypt Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
- 9.5 Nigeria Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
- 9.6 South Africa Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
10 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Segment by Type
- 10.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Market Share by Type (2014-2019)
- 10.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast by Type (2019-2024)
- 10.3 Gastroenteropancreatic Neuroendocrine Tumor Revenue Growth Rate (2014-2024)
- 10.4 Foregut Neuroendocrine Tumor Revenue Growth Rate (2014-2024)
- 10.5 Midgut Neuroendocrine Tumor Revenue Growth Rate (2014-2024)
- 10.6 Hindgut Neuroendocrine Tumor Revenue Growth Rate (2014-2024)
11 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Segment by Application
- 11.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Application (2014-2019)
- 11.2 Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast by Application (2019-2024)
- 11.3 Hospital Pharmacies Revenue Growth (2014-2019)
- 11.4 Retail Pharmacies Revenue Growth (2014-2019)
- 11.5 Online Pharmacies Revenue Growth (2014-2019)
12 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast (2019-2024)
- 12.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast (2019-2024)
- 12.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast by Regions (2019-2024)
- 12.3 North America Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Forecast (2019-2024)
- 12.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Forecast (2019-2024)
- 12.5 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Forecast (2019-2024)
- 12.6 South America Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Forecast (2019-2024)
- 12.7 Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
Summary:
Get latest Market Research Reports on Peptide Receptor Radionuclide Therapy (PRRT). Industry analysis & Market Report on Peptide Receptor Radionuclide Therapy (PRRT) is a syndicated market report, published as Global Peptide Receptor Radionuclide Therapy (PRRT) Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Peptide Receptor Radionuclide Therapy (PRRT) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
